Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic InfectionAleksandra Synowiec, Krzysztof Pyrć, Artur Szczepański et al.|Clinical Microbiology Reviews|2021Cited by 219
HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoVAleksandra Milewska, Krzysztof Pyrć, Ying Chi et al.|Journal of Virology|2020Cited by 102
HTCC as a highly effective polymeric inhibitor of SARS-CoV-2 and MERS-CoVAleksandra Milewska, Krzysztof Pyrć, Ying Chi et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 41
Development of an intestinal mucosa <i>ex vivo</i> co-culture model to study viral infectionsEmilia Barreto-Durán, Krzysztof Pyrć, M. Bochenek et al.|Journal of Virology|2024Cited by 4
Reversible rearrangement of the cellular cytoskeleton: A key to the broad-spectrum antiviral activity of novel amphiphilic polymersAgnieszka Dąbrowska, Krzysztof Pyrć, Paweł Botwina et al.|Materials Today Bio|2023Cited by 3